Welcome to LookChem.com Sign In|Join Free
  • or
Urea, N-(2,6-dimethylphenyl)-N'-4-pyridinyl-, also known as 1-(2,6-dimethylphenyl)-3-(4-pyridinyl)urea, is an organic compound with the chemical formula C14H14N2O. It is a white crystalline solid that is soluble in organic solvents. Urea, N-(2,6-dimethylphenyl)-N'-4-pyridinyl- is a derivative of urea, featuring a 2,6-dimethylphenyl group attached to the nitrogen atom and a 4-pyridinyl group attached to the other nitrogen atom. It is used in various chemical and pharmaceutical applications, such as a building block in the synthesis of certain pharmaceuticals and agrochemicals. Due to its specific structure, it can form hydrogen bonds and has potential applications in the development of new materials with unique properties.

97627-20-8

Post Buying Request

97627-20-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

97627-20-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 97627-20-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,6,2 and 7 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 97627-20:
(7*9)+(6*7)+(5*6)+(4*2)+(3*7)+(2*2)+(1*0)=168
168 % 10 = 8
So 97627-20-8 is a valid CAS Registry Number.

97627-20-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2,6-dimethylphenyl)-3-pyridin-4-ylurea

1.2 Other means of identification

Product number -
Other names N-(2,6-dimethylphenyl)-N'-4-pyridinyl urea

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:97627-20-8 SDS

97627-20-8Downstream Products

97627-20-8Relevant academic research and scientific papers

Phosgene-free synthesis of N-Aryl-N'-(4-pyridinyl)ureas via selenium-catalyzed oxidative carbonylation of 4-Aminopyridine with aromatic amines

Zhang, Xiaopeng,Li, Zhengwei,Wang, Yan,Dong, Shuxiang,Niu, Xueli,Zhang, Guisheng

, p. 197 - 209 (2016/10/22)

A facile, phosgene-free approach with high atom economy has been developed for the synthesis of N-Aryl-N'-(4-pyridinyl)ureas. With cheap selenium as the catalyst, carbon monoxide (instead of phosgene) as the carbonyl reagent, N-Aryl-N'-(4-pyridinyl)ureas can be obtained in a one-pot manner mostly in moderate to good yields via oxidative cross-carbonylation of 4-Aminopyridine with a variety of aromatic amines in the presence of oxygen under atmospheric pressure. The mechanism for the synthesis of N-Aryl-N'-(4-pyridinyl)ureas is also proposed.

Methods for treating neurodegenerative diseases and disorders using N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas and other anticonvulsant compounds

-

, (2008/06/13)

The instant invention is novel uses of known N-(2,6-disubstituted phenyl)-N'-3- and 4-pyridinyl ureas and pharmaceutically acceptable acid addition salts thereof. Such compounds as N-(2-chloro-6-methylphenyl)-N'-4-pyridinyl urea monohydrochloride or N-(2,

N-phenyl-N'-pyridinylureas as anticonvulsant agents

Pavia,Lobbestael,Taylor,Hershenson,Miskell

, p. 854 - 861 (2007/10/02)

A series of N-phenyl-N'-pyridinylureas was examined for anticonvulsant activity. Extensive structure/activity investigations revealed optimal activity in the N-(2,6-disubstituted-phenyl)-N'-(4-pyridinyl)urea series, with 37 exhibiting the best overall anticonvulsant profile. Compound 37 was effective against seizures induced by maximal electroshock but did not protect mice from clonic seizures produced by the convulsant pentylenetetrazol. The overall pharmacological profile suggests that 37 would be of therapeutic use in the treatment of generalized tonic-clonic and partial seizures. Compound 37 was selected for Phase 1 clinical trials.

Anticonvulsant N-(2,6-disubstituted aromatic)-n'-pyridinyl ureas

-

, (2008/06/13)

N-(2,6-Disubstitutedphenyl)-N'-3- and 4-pyridinyl ureas and pharmaceutically acceptable acid addition salts having anticonvulsant activity are described as well as a process for their manufacture, formulations containing the compounds and a method of trea

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 97627-20-8